Philip Philip Md Phd Frcp On Promising Novel Therapies For Pancreatic Cancer Obroncology Mp3 & Mp4 Download

2:03

philip philip md, phd, frcp, on neoadjuvant chemotherapy & upfront surgery in pancreatic cancer

2:43

philip philip, md, phd, frcp, considers the impact of immunotherapy agents in pancreatic cancer

1:14

philip philip md, phd, frcp, on brca gene mutations & outcomes in pancreatic cancer

4:42

philip philip md, phd, frcp, on the apact trial in surgically resected pancreatic adenocarcinoma

4:45

philip philip, md, on whether resected pancreatic cancer patients should be offered adjuvant therapy

2:02

philip philip md, phd, frcp, provides opinion on ngs and brca gene testing in pancreatic cancer

1:50

philip philip md, phd, frcp, considers molecular subtyping of pancreatic cancer

5:17

philip philip md, phd, frcp, discusses outcomes from the polo trial in pancreatic cancer

1:49

philip philip md, phd, frcp, on screening patients at high risk for pancreatic cancer

2:39

philip philip, md, explains how physicians should test for brca in pancreatic cancer patients

2:08

philip philip, md, phd, frcp, regarding key unmet needs in pancreatic ductal adenocarcinoma

0:57

philip philip, md, provides thoughts on the role of parp inhibitors in advanced pancreatic cancer

2:04

philip philip, md, shares opinion on treatment of a brca pancreatic cancer patient

3:00

philip philip, md, on the phase 2 study comparing chemo with or without veliparib in pancreas

2:17

philip philip, md, reflects on the impact of pegph20 in met pancreatic cancer

2:51

philip philip, md, phd, frcp, on the implications of the lapact study presented at asco 2018

4:47

philip philip, md, talks about treating a newly diagnosed stage 4 pancreatic cancer patient

2:20

philip philip, md, phd, frcp, discusses the impact of the checkmate 142 study on mcrc

1:17

philip philip md, phd, frcp, on promising novel therapies for pancreatic cancer

Download video MP4

Download video MP3

Similar videos

philip philip md, phd, frcp, on neoadjuvant chemotherapy & upfront surgery in pancreatic cancer

philip philip, md, phd, frcp, considers the impact of immunotherapy agents in pancreatic cancer

philip philip md, phd, frcp, on brca gene mutations & outcomes in pancreatic cancer

philip philip md, phd, frcp, on the apact trial in surgically resected pancreatic adenocarcinoma

philip philip, md, on whether resected pancreatic cancer patients should be offered adjuvant therapy

philip philip md, phd, frcp, provides opinion on ngs and brca gene testing in pancreatic cancer

philip philip md, phd, frcp, considers molecular subtyping of pancreatic cancer

philip philip md, phd, frcp, discusses outcomes from the polo trial in pancreatic cancer

philip philip md, phd, frcp, on screening patients at high risk for pancreatic cancer

philip philip, md, explains how physicians should test for brca in pancreatic cancer patients

philip philip, md, phd, frcp, regarding key unmet needs in pancreatic ductal adenocarcinoma

philip philip, md, provides thoughts on the role of parp inhibitors in advanced pancreatic cancer

philip philip, md, shares opinion on treatment of a brca pancreatic cancer patient

philip philip, md, on the phase 2 study comparing chemo with or without veliparib in pancreas

philip philip, md, reflects on the impact of pegph20 in met pancreatic cancer

philip philip, md, phd, frcp, on the implications of the lapact study presented at asco 2018

philip philip, md, talks about treating a newly diagnosed stage 4 pancreatic cancer patient

philip philip, md, phd, frcp, discusses the impact of the checkmate 142 study on mcrc

dr. philip philip on choosing the right treatment for advanced pancreatic cancer patients